Skip to main content
. 2016 Nov 2;2016:4840762. doi: 10.1155/2016/4840762

Table 4.

Association between clinical factors and patient delay, identified by multivariate analysis.

Categorial variables ≤90 days
(n = 179)
>90 days
(n = 222)
Univariate analysis
Multivariate analysis
n (%) n (%) OR 95% CI p OR 95% CI p
Medical history
Yes 52 (50) 52 (50)
No 127 (42.8) 170 (57.2) 1.339 [0.855–2.095] 0.202 1.332 [0.827–2.145] 0.238
Earlier symptoms
Abnormal vaginal bleeding (between periods, after sex, postmenopausal)
 Yes 158 (46,3) 183 (53,7) 0.335 [0.214–0.523] 0.001 0.345 [0.218–0.548] 0.001
 No 21 (35) 39 (65)
Vaginal discharge
 Yes 31 (50) 31 (50)
 No 148 (43,7) 191 (56,3) 1.014 [0.602–1.708] 0.958
Pain (painful sex, pelvic pain, dysuria)
 Yes 92 (39.8) 139 (60.2)
 No 87 (51.2) 83 (48.8) 0.631 [0.423–0.942] 0.024 1.255 [0.812–1.940] 0.307
Personal history of cancer
Yes 2 (66.7) 1 (33.3)
No 177 (44.5) 221 (55.5) 2.497 [0.225–27.760] 0.456
Family history of cancer
Yes 23 (56.1) 18 (43.9)
No 156 (43.3) 204 (56.7) 1.671 [0.871–3.204] 0.122 1.630 [0.812–3.272] 0.170
Histopathology
Squamous cell 157 (45) 192 (55)
Adenocarcinoma 22 (42.3) 30 (57.7) 1.115 [0.619–2.010] 0.717
Stage at diagnosis
IIA-IIB 129 (53.5) 112 (46.5)
IIIA-IIIB 49 (33.8) 96 (66.2) 2.257 [1.472–3.459] 0.001 2.113 [1.348–3.314] 0.001
IVA-IVB 1 (6.7) 14 (93.3) 16.121 [2.087–124.507] 0.008 11.439 [1.431–91.443] 0.022

Model included variables that were significant on univariate analyses at p (0.20 level).

Significant at p value ≤ 0.05.